HaploX Global

HaploX is a leading provider of genetic testing solutions, specializing in gene sequencing, liquid biopsies, bioinformatics, and big data analytics. Driven by a passion for technological innovation, we aim to harness advanced science for the betterment of humanity. Our commitment is to establish ourselves as a preeminent life sciences company globally. Our laboratory adheres to stringent international best practice guidelines and is accredited by recognized bodies including the College of American Pathologists (CAP), the Clinical Laboratory Improvement Amendments (CLIA), and the European Molecular Genetics Quality Network (EMQN). This ensures the highest standards of quality and reliability in our testing processes....

Genomics,genetic testing solutions,multi-omics,next-generation sequencing,clinical genetic solutions,liquid biopsies,cancer genetic testing, precision medicine diagnostic solutions,mrd detection,bioinformatics solutions,big data analytics in healthcare,pharmaceutical drugs r&d,transcriptome,epigenome,and metabolome

Haplox global operates in the Biotechnology research industry.

Haplox global's revenue is 1m - 10m

Haplox global has 11 - 50 employees.